Clinical Trials on Coronavirus Infections in New Zealand

Total 6554 results

Sound Pharmaceuticals, Incorporated

Enrolling by invitation

SPI-1005 Treatment in Moderate COVID-19 Patients

Coronavirus Infection | Covid19 | Corona Virus Infection | Coronavirus

United States
Eiger BioPharmaceuticals

Completed

A Study to Evaluate Pegylated Interferon Lambda Monotherapy in Patients With Chronic Hepatitis Delta Virus Infection (LIMT)

Hepatitis D, Chronic

Israel, New Zealand, Pakistan
Leidos Life Sciences
United States Department of Defense

Terminated

Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 Patients (Addendum 2)

COVID-19 | Covid19 | Coronavirus Disease 2019 | SARS-CoV2 Infection | SARS-CoV-2 Acute Respiratory Disease | COVID-19 Pandemic | COVID-19 Virus Infection | COVID-19 Virus Disease | 2019 Novel Coronavirus Disease | 2019 Novel Coronavirus Infection | 2019-nCoV Disease | 2019-nCoV Infection

United States
Novira Therapeutics, Inc.

Completed

Safety and Efficacy Study of NVR 3-778 in Healthy Volunteers and Hepatitis B Patients

Chronic Hepatitis B

New Zealand
Assembly Biosciences

Completed

A First in Human Study to Assess Safety, Tolerability, Pharmacokinetics of ABI-4334 in Healthy Subjects

Chronic Hepatitis B

New Zealand
Pardes Biosciences, Inc.

Completed

Study of PBI-0451 in Healthy Subjects.

Covid19

New Zealand
Arbutus Biopharma Corporation

Recruiting

Safety, Tolerability, PK & PD of AB-101 Following Oral Administration in Healthy and CHB Subjects.

Chronic Hepatitis b

New Zealand
University of Auckland, New Zealand

Completed

Humidification in Laparoscopic Colonic Surgery

Peritoneal Inflammation

New Zealand
Maimonides Medical Center

Terminated

Hyperbaric Oxygen Therapy in Non-ventilated COVID-19 Patients (HBOT)

COVID, Coronavirus

United States
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity of Two Dosages of Inactivated, Split-Virion Influenza Vaccine Given by an Alternate Route in the Elderly

Influenza | Orthomyxoviridae Infection | Myxovirus Infection

Australia, New Zealand
Murdoch Childrens Research Institute
Royal Children's Hospital

Recruiting

Single Dose Intravenous Antibiotics for Complicated Urinary Tract Infections in Children (CHOICE UTI)

Infection | Pediatric Infectious Disease | Complicated Urinary Tract Infection

Australia, New Zealand
Trek Therapeutics, PBC

Completed

A Study of Faldaprevir, TD-6450 and Other Antivirals in Participants With Genotype 1b Hepatitis C Virus Infection

Chronic Hepatitis C | Hepatitis C Genotype 1 | Hepatitis C (HCV) | Hepatitis C Viral Infection

United States, New Zealand
Institut Pasteur
Institut Pasteur de Nouvelle-Calédonie; Centre Hospitalier Territorial de Nouvelle-Calédonie and other collaborators

Completed

Household Transmission Investigation Study for COVID-19 in Tropical Regions (EPI-COVID-19)

Severe Acute Respiratory Syndrome | Coronavirus Infections | SARS-CoV Infection

French Guiana, Guadeloupe, New Caledonia
Thermo Fisher Scientific, Inc

Completed

Butterfly - Clinical Performance Study

Coronavirus Infections | COVID-19

United States
Bellerophon Pulse Technologies

Terminated

A Study to Assess Pulsed Inhaled Nitric Oxide vs Placebo in Subjects With Mild or Moderate COVID-19 (COViNOX)

COVID-19 | Coronavirus Infection | Coronavirus

United States
Virion Therapeutics

Recruiting

Dose-Escalation Prime/Boost Therapeutic Vaccination Study Of 2 Chimp Adenoviral Vectors in Adults With Chronic HBV On Nucleos(t)Ide Therapy

Chronic Hepatitis B

Hong Kong, New Zealand
Rutgers, The State University of New Jersey

Active, not recruiting

Rutgers COVID-19 Cohort Study

SARS-CoV-2 | Coronavirus

United States
RedHill Biopharma Limited

Completed

A Study of Opaganib in Coronavirus Disease 2019 Pneumonia (COVID-19)

Coronavirus Infections

United States, Israel
NeuroActiva, Inc.
Biomed Industries, Inc.

Recruiting

NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection (NATADEX)

Coronavirus Infection | Severe Acute Respiratory Syndrome Coronavirus 2 | Severe Acute Respiratory Infection

United States
MP Biomedicals, LLC
EDP Biotech

Completed

COVID-19 MP Biomedicals SARS-CoV-2 Ag OTC: Clinical Evaluation

COVID-19 | SARS-CoV2 Infection

United States
BLIS Technologies Limited

Recruiting

Assessment of Colonisation and Skin Quality Parameter Improvement by Probiotic Micrococcus Luteus Q24 Balm in Healthy Adults.

Microbial Colonization

New Zealand
BLIS Technologies Limited

Recruiting

Colonisation Efficacy of a Probiotic Chewing Gum.

Microbial Colonization

New Zealand
BLIS Technologies Limited

Recruiting

Colonisation Efficacy of Oral Probiotic Fast Melt Powder

Microbial Colonization

New Zealand
Rush University Medical Center
The University of Texas Health Science Center, Houston; University of California... and other collaborators

Active, not recruiting

Innovative Support for Patients With SARS-COV2 Infections (COVID-19) Registry (INSPIRE) (INSPIRE)

Cardiovascular Diseases | Neurocognitive Disorders | Covid19 | ME/CFS | Novel Coronavirus Infection | SARS COV2

United States
Gilead Sciences

Completed

Pharmacokinetics of Voxilaprevir in Adults With Normal Hepatic Function and Moderate or Severe Hepatic Impairment

HCV Infection

United States, Germany, New Zealand
Aetion, Inc.

Completed

Dexamethasone and COVID-19 Inpatient Mortality

Coronavirus

United States
Syneos Health
US Specialty Formulations, LLC

Completed

First-In-Human Study Of Orally Administered CoV2-OGEN1 In Healthy Subjects

SARS-CoV-2 (COVID-19)

New Zealand
Bayer

Completed

An Observational Study, Called ROCURS, to Learn About COVID-19 Related Outcomes in People With Cancer Who Are Treated With Tyrosine Kinase Inhibitors (TKIs) Including Regorafenib or Sorafenib (ROCURS)

Coronavirus Disease 2019 (COVID-19) | SARS-CoV-2 Infection | Malignant Solid Tumors

United States
Novartis
Novartis Pharmaceuticals

Completed

Telbivudine Versus the Combination of Telbivudine and Valtorcitabine in Patients With Chronic Hepatitis B

Hepatitis B

Hong Kong, Singapore, New Zealand
BLIS Technologies Limited

Not yet recruiting

Colonisation of Scalp by Topical Probiotic Micrococcus Luteus Q24

Microbial Colonization

New Zealand
BLIS Technologies Limited

Not yet recruiting

Probiotic Toothpaste to Assess Microbial Colonization

Microbial Colonization

New Zealand
John Hale

Recruiting

Probiotic Toothpaste for Microbial Colonization

Microbial Colonization

New Zealand
John Hale

Recruiting

Microbial Colonization of Dairy Free Oral Probiotics

Microbial Colonization

New Zealand
Pharming Technologies B.V.

Completed

Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19

Confirmed Coronavirus Disease

United States
Rutgers, The State University of New Jersey
National Institute of Dental and Craniofacial Research (NIDCR)

Completed

Rutgers Pilot for PREDICT- Patient LAB Test

SARS-CoV2 Infection

United States
BLIS Technologies Limited

Recruiting

Microbial Colonization of Oral Probiotics

Microbial Colonization

New Zealand
BLIS Technologies Limited

Active, not recruiting

Colonization of Skin by M. Luteus Q24 Probiotic

Microbial Colonization

New Zealand
NYU Langone Health

Completed

Predicting Favorable Outcomes in Hospitalized Covid-19 Patients

COVID | Corona Virus Infection | Adverse Event

United States
Valneva Austria GmbH

Completed

Safety and Immunogenicity of VLA2001 Adults Aged ≥56 Years

SARS-CoV-2 Virus Infection

New Zealand
Pulmoquine Therapeutics, Inc
Rockefeller University

Completed

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Orally Inhaled Aerosolized Hydroxychloroquine Sulfate in Healthy Adult Volunteers

Severe Acute Respiratory Syndrome Coronavirus 2

United States
Rutgers, The State University of New Jersey
National Institute of Dental and Craniofacial Research (NIDCR)

Completed

Rutgers Pilot for Dental Health Care Worker SARS-CoV-2 Testing (PREDICT-DHCW)

SARS-CoV2 Infection

United States
Aligos Therapeutics

Terminated

A Study of ALG-020572 Drug to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single Doses in Healthy Volunteers and Multiple Doses in CHB Subjects

Chronic Hepatitis B

United Kingdom, New Zealand
Medical College of Wisconsin

Completed

Self-sampling for the Study of COVID-19

Coronavirus

United States
Gilead Sciences

Completed

Safety, Tolerability and Antiviral Activity of Selgantolimod in Virally-Suppressed Participants With Chronic Hepatitis B

Chronic Hepatitis B

United States, New Zealand
Hoffmann-La Roche

Completed

A Study of Peginterferon Alfa-2a in Participants With Chronic Hepatitis B Virus (HBV) in an Expanded Access Program

Hepatitis B, Chronic

New Zealand
NYU Langone Health

Recruiting

NIH RECOVER Tissue Pathology: Understanding the Long-Term Impact of COVID-19

COVID-19 | SARS CoV 2 Infection

United States
Rutgers, The State University of New Jersey
University of Alabama at Birmingham; University of Illinois at Chicago; National... and other collaborators

Completed

PREDICT: A PBRN Feasibility Study on COVID-19 Screening in Dental Practice (PREDICT)

COVID-19 Infection

United States
Rutgers, The State University of New Jersey
National Institute of Dental and Craniofacial Research (NIDCR)

Completed

Rutgers Pilot for PREDICT- Patient POC Test

SARS CoV 2 Infection

United States
Rutgers, The State University of New Jersey

Withdrawn

Asymptomatic COVID-19 Trial (ACT)

SARS-CoV-2 Infection

United States
Mylan Inc.
Theravance Biopharma

Completed

7 Days of TD-4208 in Subjects With Chronic Obstructive Pulmonary Disease

COPD

New Zealand

Clinical Trials on Coronavirus Infections in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burundi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations